secwatch / observer
8-K filed March 23, 2026, 7:59 PM ET ticker ORA CIK 0001296445
debt confidence high sentiment positive materiality 0.75

ORMAT TECHNOLOGIES, INC. (ORA): debt financing — Ormat closes $1B convertible note offering; repurchases $286M of 2027 notes and $25M common stock

ORMAT TECHNOLOGIES, INC.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.99

ORMAT TECHNOLOGIES, INC. incurred convertible notes of $1 billion aggregate principal amount with U.S. Bank Trust Company, National Association, as trustee at 1.50% per year for Series A Notes; 0.00% for Series B Notes maturing March 15, 2031.

Instrument
convertible notes
Principal
$1 billion aggregate principal amount
Counterparty
U.S. Bank Trust Company, National Association, as trustee
Rate
1.50% per year for Series A Notes; 0.00% for Series B Notes
Maturity
March 15, 2031
Event
incurrence
Exact text from the filing
On March 20, 2026, Ormat Technologies, Inc. (the "Company") completed its previously announced offering of $1 billion aggregate principal amount of convertible senior notes, consisting of (i) $825 million aggregate principal amount of 1.50% Series A Convertible Senior Notes due 2031 (the "Series A Notes") and (ii) $175 million aggregate principal amount of 0.00% Series B Convertible Senior Notes due 2031 (the "Series B Notes" and, together with the Series A Notes, the "Notes"), in each case, including the exercise in full of the initial purchasers' options to purchase an additional $100 million and $25 million of Series A Notes and Series B Notes, respectively.
View on SEC.gov
Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

ORMAT TECHNOLOGIES, INC. issued convertible note to initial purchasers for $1 billion aggregate principal amount.

Security
convertible note
Purchaser
initial purchasers
Consideration
$1 billion aggregate principal amount
Exact text from the filing
into a Material Definitive Agreement Convertible Notes Indentures On March 20, 2026, Ormat Technologies, Inc. (the “Company”) completed its previously announced offering of $1 billion aggregate principal amount of convertible senior notes, consisting of (i) $825 million aggregate principal amount of 1.50% Series A Convertible Senior Notes due 2031 (the “Series
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

ORMAT TECHNOLOGIES, INC. entered into Series A Notes Indenture with U.S. Bank Trust Company, National Association valued at $1 billion aggregate principal amount of convertible senior notes (effective 2026-03-20).

Action
entry
Agreement
notes offering
Counterparty
U.S. Bank Trust Company, National Association
Value
$1 billion aggregate principal amount of convertible senior notes
Effective
2026-03-20
Exact text from the filing
On March 20, 2026, Ormat Technologies, Inc. (the "Company") completed its previously announced offering of $1 billion aggregate principal amount of convertible senior notes
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

ORMAT TECHNOLOGIES, INC. entered into Series B Notes Indenture with U.S. Bank Trust Company, National Association valued at $1 billion aggregate principal amount of convertible senior notes (effective 2026-03-20).

Action
entry
Agreement
notes offering
Counterparty
U.S. Bank Trust Company, National Association
Value
$1 billion aggregate principal amount of convertible senior notes
Effective
2026-03-20
Exact text from the filing
The Series B Notes were issued pursuant to an indenture, dated March 20, 2026 (the "Series B Notes Indenture" and, together with the Series A Indenture, the "Indentures"), between the Company and the Trustee.
View on SEC.gov

36 debt financings filed in the last 30 days. Browse all debt financings →

ORMAT TECHNOLOGIES, INC. filing history →

Source: SEC EDGAR
accession 0001213900-26-032467
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.